|
In May
2000, the FDA found fault with an advertisement in the New England
Journal of Medicine that it said promoted OxyContin
in a "false or misleading" way. The advertisement
"suggests that OxyContin
has been studied in all types of arthritis and can be used as
first-line therapy for the treatment of osteoarthritis,"
according to a letter from the FDA to Purdue. In 2001, the Food and
Drug Administration required Purdue to print a warning on the OxyContin
label underscoring how the drug should be used. It states that the
drug has the potential for abuse similar to morphine and is for
people with "moderate to severe pain when a continuous,
around-the-clock" painkiller is needed. In
2004, number of consumer groups and individuals filed a
lawsuit against Purdue Pharm, the manufacturer of Oxycontin,
claiming that the drug maker reaped billions in unlawful profit from
consumers through fraudulent patents and sham lawsuits that blocked
generic alternatives to the widely prescribed pain reliever. The
suit alleges that Purdue has been illegally marketing and selling
OxyContin since December 1995, when it received approval from the
Food and Drug Administration
If
you have experienced severe side effects due to this medication,
seek an attorney, or find a firm devoted to class actions against
Purdue Pharm.
|
|